+ Watch LCAV
on My Watchlist
The Company is a provider of fixed-site laser vision correction services at our LasikPlus vision centers.
Losing money - no end in sight.
I am hearing more and more success stories from senior citizens. When your grandfather ends up having better vision than you do it really makes you think twice about it; could Lasik see a recovery? Perhaps it is time...
Odd management structure -- no CEO, but has two "Co-Principal Executive Officers" instead. That arrangement seems unstable, and to date, has not delivered good results.
Five star stock bouncing off a recent decline.
As has been pointed out by hudaman, with an improvement in the economy, pent up demand will eventually turn into purchases of this elective, but highly popular, corrective surgery.I was at the Portland (actually Tigard) office last year, and met a young man who had had the surgery a year earlier, and now was driving for his friend who was "under the knife" as we spoke. A year into it, he was practically ecstatic about the results, AND about LCAV.But contrary to hudaman, given the current unemployment situation, I don't think that we will see a huge upsurge for some time. Perhaps it is oversold and we will see a strong pick up in the short term ( and $12 would be 4 x $3 if you got in then), but I think the move back to the 30s is gong to be a year or two off. But as soon as this company goes back to a profit - watch out! So I think it is a good idea to keep an eye on it!
As the economy turns around, discretionary income will increase, and people will have the money to spend on luxuries like lasek surgery.
Will go down
great price too much beaten down for suck kind of industry laser lasik stock
Great dividend. 7.87 PE. P/S .81. Operating margin 15%. ROE 32%. Beta 2.92. total debt to equity .06. Payout ratio 44%. Earnings estimate is negative but i believe lots of baby boomers will someday want lasik and the Competition does not seem stronger to me, nor the website look better. it will be important to see costs going down, while maintining R and D.
Highly profitable, growing, paying a fat dividend, and trading at a huge discount.Of course, LCAV will suffer in the short term if consumers reduce spending, but a drop in profits is already priced in. In the long run, people will continue to get LASIK at increasing rates and for more types of eye problems, and LCAV will collect the cash.
I just had the LASIK procedure done this week, and my wife had it done last summer. The staff and screening people were knowledgeable and able to answer all my questions to my satisfaction. I've spent many days and hours learning about the procedure and the company. Yes, they had a downsizng recently and I also blame the overall economic situation of our country, combined with the typical instability of the coming Presidential election. I do see this stock remaining at this level for a while yet, so I'm getting in while the getting is good. Once the election is over, and the economy woes settledown, I see this as a big asset and would expect it to return to it's previous high within the next 18 - 24 months.. Medical that pays dividends is worth the risk in my opinion'
LASIK vision correction service provider that has been kicked to the curb on signs that business is slowing and visibility is diminishing. At this point, the baby has been thrown out with the bath water. As management gets more visibility on the company's business and as investors realize that LCAV is still a great way to play the increasing popularity of LASIK, the stock should recover.
provider of lasik surgery - it isn't going away anytime soon. the recent downtrend is only more reason to pick up this stock...right now its CHEAP...its got strong numbers and is going to be around for a while.
eventually everyone with glasses will have this done.
just look at that pe
One year play. Oversold following overreaction to 4q revenue, strong short interest, and an over reaction to a downgrade. All the pieces for a solid company to jump up in price.
The stock has trended sharply down given the slowing economy and reduced number of procedures. That said, the company is rock solid. It has about $3 in cash per share. It has operating cash flow that more than covers its dividend and some share buybacks. Ultimately, LASIK is a growth business and will become increasingly more common. At a price of $14-15 a share, the stock is cheap and has a lot of upside leverage as the economy improves.
This one is a steal at this price
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions